MENU
Showcases Stock ranks Forex

ADMA Biologics Inc. (ADMA)
2.38  -0.03 (-1.24%) 09-18 16:00
Open: 2.4 Pre. Close: 2.41
High: 2.44 Low: 2.35
Volume: 2,759,441 Market Cap: 206M
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The company is headquartered in Ramsey, New Jersey and currently employs 318 full-time employees. The firm is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 2.443 - 2.456 2.456 - 2.467
Low: 2.32 - 2.334 2.334 - 2.347
Close: 2.356 - 2.381 2.381 - 2.402
Stock Technical Analysis
Overall:     
Target: Six months: 3.59
One year: 4.33
Support: Support1: 2.04
Support2: 1.70
Resistance: Resistance1: 3.07
Resistance2: 3.71
Pivot: 2.36
Moving Averages: MA(5): 2.38
MA(20): 2.45
MA(100): 2.85
MA(250): 3.42
MACD: MACD(12,26): -0.14
Signal(12,26,9): -0.17
%K %D: %K(14,3): 43.00
%D(3): 38.70
RSI: RSI(14): 42.76
52-Week: High: 5.45
Low: 1.45
Change(%): -54.1
Average Vol(K): 3-Month: 622751
10-Days: 254135
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

ADMA has closed below upper band by 45.6%. Bollinger Bands are 27.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 18 Sep 2020
Stocks To Trade: ADMA Biologics, Inc. (ADMA) Attracting Wallstreet Traders - investmillion.com

Thu, 17 Sep 2020
Is ADMA Biologics, Inc. (ADMA) a Keeper? - The News Heater

Tue, 15 Sep 2020
ADMA Biologics Inc. (ADMA) latest performance of 5.80% is not what was on cards - News Daemon

Mon, 14 Sep 2020
Small Cap Stock ADMA Biologics, Inc. (ADMA) is a Buy – Analysts - marketingsentinel.com

Wed, 09 Sep 2020
Market Analysts see ADMA Biologics Inc. [ADMA] gaining to $8. Time to buy? - The DBT News

Wed, 09 Sep 2020
ADMA Biologics to Participate in Morgan Stanley Virtual Healthcare Conference - GlobeNewswire

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 86.35
Shares Float (M) 67.88
% Held by Insiders 7.35
% Held by Institutions 47.91
Shares Short (K) 13310
Shares Short Prior Month (K) 9810
Stock Financials
EPS -0.881
Book Value (p.s.) 0.890
Profit Margin -164.91
Operating Margin -136.31
Return on Assets (ttm) -19.0
Return on Equity (ttm) -99.2
Qtrly Rev. Growth 18.7
Gross Profit (p.s.) -0.118
Sales Per Share 0.431
EBITDA (p.s.) -0.550
Qtrly Earnings Growth
Operating Cash Flow (M) -89.21
Levered Free Cash Flow (M) -74.98
Stock Valuation
PE Ratio -2.70
PEG Ratio
Price to Book value 2.67
Price to Sales 5.52
Price to Cash Flow -2.30
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator